Article info
Stem-cell derived gametes
Reproductive technologies, risk, enhancement and the value of genetic relatedness
- Correspondence to Dr Robert Sparrow, Faculty of Arts, Department of Philosophy, Monash University, Clayton, VIC 3800, Australia; robert.sparrow{at}monash.edu
Citation
Reproductive technologies, risk, enhancement and the value of genetic relatedness
Publication history
- Received January 19, 2014
- Accepted February 3, 2014
- First published March 6, 2014.
Online issue publication
October 20, 2014
Article Versions
- Previous version (6 March 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- In vitro eugenics
- Some doubts about in vitro eugenics as a human enhancement technology
- Moral reasons to edit the human genome: picking up from the Nuffield report
- Possible people, complaints, and the distinction between genetic planning and genetic engineering
- Sexism and human enhancement
- Multiplex parenting: IVG and the generations to come
- Language matters
- ‘My child will never initiate Ultimate Harm’: an argument against moral enhancement
- Guerrilla eugenics: gene drives in heritable human genome editing
- Artificial gametes: new paths to parenthood?